Intracystic injection of methotrxate in postmenopausal female suffering from simple ovarian cyst with low malignancy index .

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR201810634381311

Enrollment

Registered

2018-10-30

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postmenopausal ovarain cyst

Interventions

methotrxate group

follow up group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1- Postmenopausal female 2- Simple ovarian cyst 3- Calculated malignancy index is less than 25 ( low malignancy index)

Exclusion criteria

Exclusion criteria: 1- Medical disorders like liver disease or renal disease 2- Known to have allergy to methotrexate 3- Her blood picture shows low leucocytes count 4- She had previous pelvic surgery with rising suspicious of presence old dense pelvic adhesions

Design outcomes

Primary

Measure	Time frame
•Recurrence of the cyst.	—

Secondary

Measure	Time frame
Change in the cyst size. • Occurrence of complications related to the cyst ( rupture , heamorrahge…) • Appearance of a new symptoms • Need of other surgical interference like exploration • Post operative complication : like postoperative pain , postoperative sepsis ,	—

Countries

Egypt

Contacts

Public Contactahmed elkhyat

lecturer of obesterics and gynecology

ahmedelkhyat81@gmail.com0201007981804

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026